Literature DB >> 8123487

Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.

T R Evans1, M G Rowlands, M Law, R C Coombes.   

Abstract

Oestrone sulphatase is an important source of local synthesis of biologically active oestrogens in human breast cancer. The oestrone sulphatase enzyme in the particulate fraction of human breast carcinoma was characterised. The Km was 8.91 microM, and the Vmax was 0.022 nmol min-1 mg-1. Oestrone sulphatase activity was detected in 93 of 104 human breast carcinoma samples (89%), and mean activity was 0.041 nmol min-1 mg-1 (range 0-0.399 nmol min-1 mg-1). There was no significant correlation between intratumoral oestrone sulphatase activity and oestrogen receptor status, or with any other prognostic factors. Intratumoral enzyme levels were not associated with time to recurrence or with overall survival time. It thus appears that, although a useful source of intratumoral oestrogens, oestrone sulphatase activity is not of prognostic significance in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123487      PMCID: PMC1968849          DOI: 10.1038/bjc.1994.101

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Determination of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography.

Authors:  D S Millington
Journal:  J Steroid Biochem       Date:  1975 Mar-Apr       Impact factor: 4.292

Review 2.  Etiology of human breast cancer: a review.

Authors:  B MacMahon; P Cole; J Brown
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

3.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  Source of estrogen production in postmenopausal women.

Authors:  J M Grodin; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

5.  Surgical treatment of breast cancer. Trends and factors affecting survival.

Authors:  W S Payne; W F Taylor; S Khonsari; J H Snider; E G Harrison; H Golenzer; O T Clagett
Journal:  Arch Surg       Date:  1970-08

Review 6.  Cancer of the breast: the past decade (first of two parts).

Authors:  I C Henderson; G P Canellos
Journal:  N Engl J Med       Date:  1980-01-03       Impact factor: 91.245

7.  Treatment of curable carcinoma of the breast.

Authors:  C D Haagensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

8.  A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma.

Authors:  J B Adams; T Pewnim; D P Chandra; L Archibald; M S Foo
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

9.  Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.

Authors:  S J Santner; B Ohlsson-Wilhelm; R J Santen
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

10.  Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients.

Authors:  P Valagussa; G Bonadonna; U Veronesi
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

View more
  8 in total

Review 1.  Molecular therapy of breast cancer: progress and future directions.

Authors:  Sheng-Xiang Lin; Jiong Chen; Mausumi Mazumdar; Donald Poirier; Cheng Wang; Arezki Azzi; Ming Zhou
Journal:  Nat Rev Endocrinol       Date:  2010-07-20       Impact factor: 43.330

2.  The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.

Authors:  Aurora Shehu; Constance Albarracin; Y Sangeeta Devi; Kristin Luther; Julia Halperin; Jamie Le; Jifang Mao; Rachel W Duan; Jonna Frasor; Geula Gibori
Journal:  Mol Endocrinol       Date:  2011-03-03

3.  The Role of Androgens in Normal and Malignant Breast Tissue.

Authors:  Katharina Tiefenbacher; Günter Daxenbichler
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

4.  Expression of Estrogen Sulfotransferase 1E1 and Steroid Sulfatase in Breast Cancer: A Immunohistochemical Study.

Authors:  D Poisson Paré; D Song; V Luu-The; B Han; S Li; G Liu; F Labrie; G Pelletier
Journal:  Breast Cancer (Auckl)       Date:  2009-03-20

5.  In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.

Authors:  Keely M McNamara; Fouzia Guestini; Torill Sauer; Joel Touma; Ida Rashida Bukholm; Jonas C Lindstrøm; Hironobu Sasano; Jürgen Geisler
Journal:  Br J Cancer       Date:  2018-03-22       Impact factor: 7.640

6.  Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder.

Authors:  Naomi Sato; Kazue Ise; Shuko Hata; Shinichi Yamashita; Akihiro Ito; Hironobu Sasano; Yasuhiro Nakamura
Journal:  Pathol Oncol Res       Date:  2021-04-15       Impact factor: 3.201

7.  Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma.

Authors:  Borbála Vincze; Bence Kapuvári; Nóra Udvarhelyi; Zsolt Horváth; Zoltán Mátrai; Ferenc Czeyda-Pommersheim; Krisztina Kőhalmy; Judit Kovács; Mariann Boldizsár; István Láng; Miklós Kásler
Journal:  Springerplus       Date:  2015-07-31

8.  Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells.

Authors:  Dong-Jin Ye; Yeo-Jung Kwon; Sangyun Shin; Hyoung-Seok Baek; Dong-Won Shin; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.